Ross' remarks to our article1 give us the welcome opportunity to explain our position in more detail. Our point is that there are not enough best-interest arguments to deny genetic testing to an adolescent at risk of carrying a BRCA1 mutation. Therefore, guidelines should differentiate between children and adolescents. The question is, "Are there compelling justifications, ethical or practical, to wait until the adolescent reaches the age of majority?"2
Elger BS, Harding TW. Genetic Testing of Adolescents: Is It in Their Best Interest? Arch Pediatr Adolesc Med. 2000;154(8):850–851. doi:
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: